777 SAFETY, TOLERABILITYAND PHARMACOKINETIC OF MULTIPLE ASCENDING DOSES OF THE EP-1 RECEPTOR ANTAGONIST ONO-8539, A POTENTIAL NEW AND NOVEL THERAPY TO OVERACTIVE BLADDER IN HEALTHY YOUNG AND ELDERLY SUBJECTS

詳細情報 詳細情報について

• CRID

  1360855568944938240

• DOI

  10.1016/s1569-9056(10)60760-9

• ISSN

  15699056

• Web Site

  https://api.elsevier.com/content/article/PII:S1569905610607609?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1569905610607609?httpAccept=text/plain

• データソース種別

  • Crossref